A Multicenter Phase Ii Trial Of Trifluridine/Tipiracil In Combination With Cetuximab In Ras Wild-Type Metastatic Colorectal Cancer Patients Refractory To Prior Anti-Egfr Antibody Therapy: The Wjog8916g Trial
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要